Veeva SystemsVEEV
VEEV
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 10 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
62% more first-time investments, than exits
New positions opened: 131 | Existing positions closed: 81
24% more call options, than puts
Call options by funds: $358M | Put options by funds: $289M
3% more funds holding
Funds holding: 940 [Q3] → 971 (+31) [Q4]
1.21% more ownership
Funds ownership: 79.16% [Q3] → 80.36% (+1.21%) [Q4]
6% more repeat investments, than reductions
Existing positions increased: 351 | Existing positions reduced: 331
1% more capital invested
Capital invested by funds: $26.9B [Q3] → $27.2B (+$334M) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 16 [Q3] → 16 (+0) [Q4]
Research analyst outlook
10 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$200
15%
downside
Avg. target
$241
3%
upside
High target
$285
22%
upside
10 analyst ratings
4 positive
40%
4 neutral
40%
2 negative
20%
JP Morgan Anne Samuel 51% 1-year accuracy 18 / 35 met price target | 6%upside $249 | Neutral Maintained | 20 Mar 2025 |
Scotiabank Allan Verkhovski 42% 1-year accuracy 5 / 12 met price target | 5%upside $245 | Sector Perform Maintained | 6 Mar 2025 |
Truist Securities Joe Meares 0 / 0 met price target | 7%downside $217 | Hold Maintained | 6 Mar 2025 |
Stephens & Co. Jeff Garro 55% 1-year accuracy 6 / 11 met price target | 20%upside $280 | Overweight Reiterated | 6 Mar 2025 |
Morgan Stanley Craig Hettenbach 29% 1-year accuracy 2 / 7 met price target | 14%downside $201 | Underweight Maintained | 6 Mar 2025 |
Financial journalist opinion
Based on 25 articles about VEEV published over the past 30 days
Positive
Investors Business Daily
4 days ago
China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market
Boosted by partnerships with Big Pharma and a push into China, Veeva continues to battle to break out in troubled market. The post China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market appeared first on Investor's Business Daily.

Positive
Zacks Investment Research
1 week ago
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Neutral
PRNewsWire
1 week ago
Indero Marks 40th Study Live with Veeva RTSM
Specialized CRO standardizes on Veeva RTSM to drive operational efficiency and faster study timelines PLEASANTON, Calif. , March 19, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Indero, formerly Innovaderm Research, successfully launched its 40th RTSM study on Veeva RTSM.

Positive
Seeking Alpha
1 week ago
Veeva Systems: Staying Buy Rated As VEEV Is Executing Well
I reaffirm my buy rating on Veeva Systems due to strong 4Q25 results, driven by R&D growth and positive Vault CRM adoption traction. VEEV's revenue grew 14% y/y to $721 million, beating expectations, with significant margin improvements and a strong balance sheet. Vault CRM added 20 new customers, with multiple top 20 pharma commitments expected in 2025, signaling positive transition progress.

Neutral
Zacks Investment Research
1 week ago
Veeva (VEEV) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Positive
Zacks Investment Research
1 week ago
Best Momentum Stock to Buy for March 17th
PSO, VEEV and PAA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 17, 2025.

Positive
Zacks Investment Research
1 week ago
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.

Neutral
FXEmpire
2 weeks ago
Veeva Shares Advance on Revenue, AI Growth
Life-sciences focused cloud solutions provider Veeva Systems, Inc. (VEEV) is beating Big Money expectations.

Positive
Zacks Investment Research
2 weeks ago
Here's Why You Should Add Veeva Systems Stock to Your Portfolio Now
VEEV's robust product portfolio and a slew of strategic deals raise optimism about the stock.

Positive
Zacks Investment Research
2 weeks ago
Veeva (VEEV) Upgraded to Strong Buy: Here's Why
Veeva (VEEV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Charts implemented using Lightweight Charts™